www.fdanews.com/articles/199229-lumen-bioscience-grabs-4-million-federal-grant-to-develop-covid-19-drug
Lumen Bioscience Grabs $4 Million Federal Grant to Develop COVID-19 Drug
September 25, 2020
Lumen Biosciences has received a $4 million grant from the U.S. Army Medical Research and Development Command to develop a drug to treat gastrointestinal infection in COVID-19 patients and to potentially block disease transmission.
The funding will support the development of the drug and initial work on a large-scale manufacturing plant capable of producing 1 billion doses of the drug per year.
Lumen plans to launch phase 2 clinical trials of the drug and to finish production on its manufacturing facility next year.